Call Number (LC) Title Results
RM281 .W745 V&B annual report / 1
RM282.A5 S8 1967 Antilymphocytic serum / 1
RM282.C95 B56 1999 Biological characterization and assay of cytokines and growth factors : National Institute for Biological Standards and Control, Potters Bar, Herts., U.K., September 10-12, 1997 / 1
RM282.C95 C96 2001 Cytokine inhibitors / 1
RM282.C95 C964 2001 Cytokine therapeutics in infectious diseases / 1
RM282.C95 C964x 2001 Cytokine therapeutics in infectious diseases / 1
RM282.C95 C977 2006 Cytokines as potential therapeutic targets for inflammatory skin diseases / 1
RM282.C95 C977 2006eb Cytokines as potential therapeutic targets for inflammatory skin diseases 1
RM282.C95 C98 1998 Cytokines 1
RM282.C95 F34 1999 Cytokines and cell homeostasis in the gastrointestinal tract : proceedings of the Falk Symposium 113 held in Regensburg, Germany, 16-18 September, 1999 / 1
RM282.I44 B56 2022 Biotechnology in the modern medicinal system : advances in gene therapy, immunotherapy, and targeted drug delivery / 1
RM282.I44 H36 2014 Handbook of Therapeutic Antibodies
Handbook of Therapeutic Antibodies / 		2
RM282.I44 I46 1991 Immunotherapy with intravenous immunoglobulins 1
RM282.I44 I5 1991 Immunotherapy with intravenous immunoglobulins : proceedings of a conference held in Interlaken 6-9 May 1990 / 1
RM282.I44 I586 1997eb Intravenous immunoglobulins in clinical practice 1
RM282.I44 T483 2008 Therapeutic antibodies 1
RM282.M65 Development of antibody-based therapeutics : translational considerations & challenges / 1
RM282.M65 C55 2020 Clinical trials of monoclonal antibodies to treat and prevent COVID-19 at Washington University. 1
RM282.M65 D48 2012 Development of antibody-based therapeutics translational considerations / 1
RM282.M65 R43 2009 Recombinant antibodies for immunotherapy / 1